Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GDC-1971 |
Synonyms | |
Therapy Description |
RLY-1971 is a selective SHP2 inhibitor, which potentially decreases tumor growth (PMID: 37774359). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GDC-1971 | RLY1971|RLY 1971|RG-6433|RG6433|RLY-1971|GDC1971|GDC 1971 | SHP2 Inhibitor 20 | RLY-1971 is a selective SHP2 inhibitor, which potentially decreases tumor growth (PMID: 37774359). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04252339 | Phase I | GDC-1971 | RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors | Completed | USA | 0 |